X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (62) 62
male (48) 48
female (44) 44
index medicus (37) 37
middle aged (34) 34
adult (32) 32
aged (26) 26
endocrinology & metabolism (24) 24
cancer (19) 19
oncology (18) 18
adrenal cortex neoplasms - drug therapy (12) 12
aged, 80 and over (11) 11
medicine, general & internal (11) 11
mortality (11) 11
prognosis (11) 11
mitotane - therapeutic use (10) 10
risk (10) 10
therapy (10) 10
adolescent (9) 9
internal medicine (9) 9
management (9) 9
research (9) 9
risk factors (9) 9
survival (9) 9
adrenocortical carcinoma (8) 8
analysis (8) 8
child (8) 8
diabetes (8) 8
netherlands - epidemiology (8) 8
retrospective studies (8) 8
survival analysis (8) 8
young adult (8) 8
adrenal cortex neoplasms - surgery (7) 7
adrenocortical carcinoma - drug therapy (7) 7
carcinoma (7) 7
medicine & public health (7) 7
mitotane (7) 7
neoplasm staging (7) 7
registries (7) 7
adrenal cortex neoplasms - blood (6) 6
adrenal cortex neoplasms - pathology (6) 6
antineoplastic agents, hormonal - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
comorbidity (6) 6
disease (6) 6
follow-up studies (6) 6
netherlands (6) 6
oncology, experimental (6) 6
survival rate (6) 6
tumors (6) 6
adrenal cortex neoplasms - diagnosis (5) 5
adrenal-cortical carcinoma (5) 5
adrenocortical carcinoma - blood (5) 5
antineoplastic agents, hormonal - pharmacokinetics (5) 5
care and treatment (5) 5
cohort studies (5) 5
diagnosis (5) 5
hypoglycemic agents - therapeutic use (5) 5
infant (5) 5
mitotane - administration & dosage (5) 5
mitotane - adverse effects (5) 5
mitotane - blood (5) 5
mitotane - pharmacokinetics (5) 5
prevalence (5) 5
thyroid neoplasms - mortality (5) 5
adrenal cortex neoplasms - metabolism (4) 4
adrenocortical carcinoma - diagnosis (4) 4
adrenocortical carcinoma - surgery (4) 4
article (4) 4
carcinoma - mortality (4) 4
child, preschool (4) 4
co-morbidity (4) 4
cohort (4) 4
colorectal neoplasms - mortality (4) 4
dose-response relationship, drug (4) 4
drug therapy (4) 4
human physiology (4) 4
mellitus (4) 4
metabolic diseases (4) 4
microbiology (4) 4
nursing (4) 4
o,p'ddd (4) 4
quality of life (4) 4
surveys and questionnaires (4) 4
survivors - psychology (4) 4
thyroid cancer (4) 4
thyroid neoplasms - psychology (4) 4
thyroid neoplasms - therapy (4) 4
time factors (4) 4
treatment (4) 4
treatment outcome (4) 4
united-states (4) 4
acquired immunodeficiency syndrome (3) 3
adherence (3) 3
adrenal cortex - pathology (3) 3
adrenal cortex neoplasms - mortality (3) 3
adrenal gland neoplasms - genetics (3) 3
adrenalectomy (3) 3
adrenocortical carcinoma - mortality (3) 3
adrenocortical carcinoma - pathology (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (3) 3
Robarts - Stacks (3) 3
Art - Oversize (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Credit Valley Hospital - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 03/2015, Volume 100, Issue 3, pp. 841 - 849
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 12/2013, Volume 98, Issue 12, pp. 4759 - 4767
Context: Mitotane is the only approved drug for treatment of adrenocortical carcinoma. Its pharmacokinetic properties are not fully elucidated and different... 
METABOLITES | THERAPY | PLASMA | PHARMACOLOGY | O,P'-DDD | ENDOCRINOLOGY & METABOLISM | MONITORED MITOTANE | O,P'DDD | CYP3A4 | CANCER | CLINICAL MANAGEMENT | Dichlorodiphenyl Dichloroethylene - blood | Adrenal Cortex Neoplasms - blood | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Gastrointestinal Diseases - physiopathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Adrenal Cortex - pathology | Antineoplastic Agents, Hormonal - pharmacokinetics | Dose-Response Relationship, Drug | Adrenocortical Carcinoma - pathology | Antineoplastic Agents, Hormonal - adverse effects | Adrenocortical Carcinoma - drug therapy | Drug Interactions | Antineoplastic Agents, Hormonal - therapeutic use | Biotransformation | Adult | Female | Adrenal Cortex - drug effects | Mitotane - administration & dosage | Severity of Illness Index | Adrenocortical Carcinoma - secondary | Antineoplastic Agents, Hormonal - administration & dosage | Mitotane - adverse effects | Adrenal Cortex Neoplasms - pathology | Mitotane - therapeutic use | Mitotane - pharmacokinetics | Adrenal Cortex Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neurotoxicity Syndromes - physiopathology | Adrenocortical Carcinoma - blood | Drug Monitoring | Neoplasm Staging | Gastrointestinal Diseases - chemically induced | Phenylacetates - blood
Journal Article
PLoS One, ISSN 1932-6203, 01/2015, Volume 10, Issue 8
Journal Article
Diabetologia, ISSN 0012-186X, 2015, Volume 58, Issue 6, pp. 1380 - 1381
Journal Article
European journal of endocrinology / European Federation of Endocrine Societies, ISSN 0804-4643, 2013, Volume 169, Issue 3, pp. 263 - 270
Journal Article
Diabetologia: clinical and experimental diabetes and metabolism, ISSN 0012-186X, 01/2012, Volume 55, Issue 1, pp. 51 - 62
textabstractAims/hypothesis Several publications suggest an association between certain types of insulin and cancer, but with conflicting results. We... 
Insulin glargine | Medicine & Public Health | Human Physiology | Metabolic Diseases | Insulin analogues | Internal Medicine | Breast cancer | Insulin | Cancer | MORTALITY | METAANALYSIS | DIABETES-MELLITUS | BREAST-CANCER | THERAPY | RESEARCH NETWORK | COLORECTAL-CANCER | ENDOCRINOLOGY & METABOLISM | MALIGNANCIES | COHORT | EXPOSURE | Follow-Up Studies | Humans | Middle Aged | Netherlands - epidemiology | Patient Admission | Male | Risk | Incidence | Dose-Response Relationship, Drug | Neoplasms - complications | Neoplasms - chemically induced | Hypoglycemic Agents - administration & dosage | Community Pharmacy Services | Female | Insulin - analogs & derivatives | Medical Record Linkage | Diabetes Mellitus, Type 2 - complications | Breast Neoplasms - epidemiology | Hypoglycemic Agents - therapeutic use | Proportional Hazards Models | Insulin, Regular, Human - adverse effects | Insulin - administration & dosage | Insulin, Regular, Human - therapeutic use | Insulin, Regular, Human - administration & dosage | Breast Neoplasms - complications | Insulin, Long-Acting - adverse effects | Insulin, Long-Acting - administration & dosage | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Breast Neoplasms - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Electronic Health Records | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin - therapeutic use | Neoplasms - epidemiology | Cohort Studies | Heterocyclic compounds | Oncology, Experimental | Research | Risk factors | Public health | Medical informatics
Journal Article
by Reznik, Y and Reznik, Y and Pender, J and Spaniolas, K and Stefan, D and Wohlgemuth, S and Mozer, A and Sippey, M and Hounshell, K and Wilinska, M.E and Hovorka, R and Hovorka, R and Hovorka, R and Hovorka, R and Haluzik, M and Loebker, W and Chase, H.P and Maahs, D and Wadwa, P and Buckingham, B and Wilson, D and Ly, T and Lum, J and Calhoun, P and Raghinaru, D and Cameron, F and Bequette, B.W and Hramiak, I and Beck, R and Remus, K and Blaesig, S and Biester, T and Fath, M and Lange, K and Kordonouri, O and Haahr, H and Jensen, L and Erichsen, L and Hompesch, M and Cobelli, C and Cobelli, C and Gibney, M and Swinney, M and Xue, Z and Mendes, G.F and Miranda, F and Batista, L.F and Lins, T.C and Colberg, S.R and Dall, M and Parkin, C and Warner, J and Rabbone, I and Minuto, N and Scaramuzza, A and Bonfanti, R and Schiaffini, R and Toni, S and Iafusco, D and Lombardo, F and Pistorio, A and Pistorio, A and De Portu, S and Cohen, O and Cohen, O and Conget, I and Conget, I and Racault, A.S and Shin, J and Runzis, S and Reznik, Y and Petitti, A and Ferrari, M and Radaelli, S and Comaschi, V and Zuccotti, G.V and Ambrosino, J and Walders-Abramson, N and Ly, T and Maahs, D and Maahs, D and Weinzimer, S and Weinzimer, S and Buckingham, B and Buckingham, B and Buckingham, B and Melmer, A and Mader, J and Schütz-Fuhrmann, I and Rose-Engels, H and Götz, G and Pfeiffer, M and Hermann, J and Stettler, C and Holl, R and Mader, J.K and Aberer, F and Poettler, T and Trautmann, M and Pieber, T and ...
Diabetes Technology & Therapeutics, ISSN 1520-9156, 02/2015, Volume 17, Issue S1, pp. A-1 - A-180
Journal Article
Thyroid, ISSN 1050-7256, 10/2013, Volume 23, Issue 10, pp. 1247 - 1255
Journal Article
Clinical Endocrinology, ISSN 0300-0664, 2011, Volume 75, Issue 4, pp. 544 - 554
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 01/2015, Volume 22, Issue 6, pp. R325 - R338
Cancer of the adrenal cortex (ACC) is a rare endocrine malignancy with limited treatment options. Patients typically present with autonomous hormonal... 
Carcinoma | Adrenal cortex | Adrenal hormone | MITOTANE TREATMENT | LONG-TERM SURVIVAL | PHASE-II | adrenal cortex | CLINICAL MANAGEMENT | LAPAROSCOPIC ADRENALECTOMY | CANCER-PATIENTS | LOCAL RECURRENCE | ONCOLOGY | carcinoma | ENDOCRINOLOGY & METABOLISM | adrenal hormone | ADJUVANT RADIOTHERAPY | SURGICAL RESECTION | ADRENAL-CORTICAL CARCINOMA | Recurrence | Adrenal Cortex Neoplasms - epidemiology | Prognosis | Genes, Neoplasm | Humans | Symptom Assessment | Gene Expression Profiling | Molecular Targeted Therapy | RNA, Neoplasm - blood | Antineoplastic Agents, Hormonal - pharmacokinetics | Adrenal Cortex Neoplasms - diagnosis | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis | Multicenter Studies as Topic | Antineoplastic Agents, Hormonal - therapeutic use | Carcinoma - epidemiology | Immunotherapy | Carcinoma - pathology | Radiotherapy, Adjuvant | Mitotane - adverse effects | Carcinoma - diagnosis | Survival Rate | Clinical Trials as Topic | Combined Modality Therapy | Adrenal Cortex Neoplasms - pathology | Cancer Care Facilities | Forecasting | Mitotane - therapeutic use | Mitotane - pharmacokinetics | Adrenal Cortex Neoplasms - genetics | Adrenal Cortex Neoplasms - therapy | Adrenalectomy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma - genetics | Carcinoma - therapy | MicroRNAs - blood | Drug Monitoring | Glucocorticoids - biosynthesis | Index Medicus
Journal Article
by Alam, Nadia and Alam, N and Oskam, E and Oskam, Erick and Stassen, P.M and Stassen, Patricia M and Exter, Pieternel van and van de Ven, P.M and van de Ven, Peter M and Haak, Harm R and Haak, H.R and Holleman, F and Holleman, Frits and Zanten, Arthur van and Leeuwen-Nguyen, Hien van and Bon, V and Bon, Victor and Duineveld, B.A.M and Duineveld, Bart A M and Nannan Panday, R.S and Nannan Panday, Rishi S and Kramer, M.H.H and Kramer, Mark H H and Nanayakkara, Prabath W B and Nanayakkara, P.W.B and van Exter, P and Goselink, J and De Kreek, A and van Grunsven, P and Biekart, M and Deddens, G.J and Weijschede, F and Rijntjes, N and Franschman, G and Janssen, J and Frenken, J and Versluis, J and Boomars, R and de Vries, G and den Boer, E and van Gent, A and Willeboer, M and Buunk, G and Timmers, G.J and Snijders, F and Posthuma, N and Stoffelen, S and Claassens, S and Ammerlaan, H and Sankatsing, S and Alsma, J and van Zanten, A and Slobbe, L and de Melo, M.M and Dees, A and Carels, G and Wabbijn, M and van Leeuwen-Nguyen, T.T.H and Assink, J and van der Honing, A and Luik, P and Poortvliet, W and Schouten, W.E.M and Veenstra, J and Holkenborg, J and Cheung, T.C and van Bokhorst, J and Kors, B and Louis- Wattel, G.H and Roeleveld, T and Toorians, A and Jellema, W and Govers, A and Kaasjager, H.A.H and Dekker, D and Verhoeven, M.A.M and Flietstra, T and Roest, L and Peters, E.J.G and Hekker, T.A.M and Ang, W and van der Wekken, W and Ghaem Maghami, P and Kanen, B and Wesselius, H and Heesterman, L and Zwietering, A.N and Stoffers, J and PHANTASI Trial Investigators and ORCA Onderzoeks Consortium Acute and PHANTASi Trial Investigators and the ORCA (Onderzoeks Consortium Acute Geneeskunde) Research Consortium the Netherlands
The Lancet Respiratory Medicine, ISSN 2213-2600, 01/2018, Volume 6, Issue 1, pp. 40 - 50
Journal Article